DePuy Synthes Announces CE Mark for BI-MENTUM Dual Mobility Hip

By Julie A. Vetalice

DePuy Synthes Announces CE Mark for BI-MENTUM Dual Mobility Hip

DePuy Synthes has been informed of CE Mark approval for the BI-MENTUM™ Dual Mobility hip for patients with a higher risk of dislocation. In addition to the burden of repeat surgeries, surgical treatment of a dislocating total hip can reportedly raise the cost of hip replacement by 342%.

BI-MENTUM features a standard femoral head articulating within a large polyethylene liner which swivels within a metal shell. Currently available in the U.S., BI-MENTUM is slated to enter European markets in April 2020. The system complements other hip stems with highly polished necks, including the company's CORAIL® Hip System that has more than 2.5 million implantations to date.

In 2018, the company entered into a distribution agreement with SERF and is now bringing dual-mobility acetabular cups, identical to Serf® dual-mobility cups, under its own BI-MENTUM brand name. This technology has a track record of 100% cup survivorship at 10 years, and an implant milestone of 165,000 cups since 2007.

“With an increasing number of patients undergoing hip replacement surgery, surgeons need to address a broader range of surgical needs to help their patients stay active and get on with their lives. Securing the CE Mark on BI-MENTUM enables us to better serve our customers and patients across Europe with a solution that is designed to make a continued difference in hip replacement,” said Aaron Villaruz, Vice President and Global Platform Leader for Hips at DePuy Synthes.

Product Labels: Hip Replacement

Tags: CE Mark, Regulatory